In silico prediction of binding sites on proteins S Leis, S Schneider, M Zacharias Current medicinal chemistry 17 (15), 1550-1562, 2010 | 110 | 2010 |
Mechanistic insights into the allosteric modulation of opioid receptors by sodium ions Y Shang, V LeRouzic, S Schneider, P Bisignano, GW Pasternak, ... Biochemistry 53 (31), 5140-5149, 2014 | 107 | 2014 |
How oliceridine (TRV-130) binds and stabilizes a μ-opioid receptor conformational state that selectively triggers G protein signaling pathways S Schneider, D Provasi, M Filizola Biochemistry 55 (46), 6456-6466, 2016 | 103 | 2016 |
CELLmicrocosmos 2.2 MembraneEditor: A Modular Interactive Shape-Based Software Approach To Solve Heterogeneous Membrane Packing Problems B Sommer, T Dingersen, C Gamroth, SE Schneider, S Rubert, J Krüger, ... Journal of chemical information and modeling 51 (5), 1165-1182, 2011 | 73 | 2011 |
Atomic resolution model of the antibody Fc interaction with the complement C1q component S Schneider, M Zacharias Molecular Immunology 51 (1), 66-72, 2012 | 63 | 2012 |
Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability RS Crowley, AP Riley, AM Sherwood, CE Groer, N Shivaperumal, ... Journal of medicinal chemistry 59 (24), 11027-11038, 2016 | 44 | 2016 |
Allosteric Modulation of Protein Arginine Methyltransferase 5 (PRMT5) RL Palte, SE Schneider, MD Altman, RP Hayes, S Kawamura, BM Lacey, ... ACS Medicinal Chemistry Letters, 2020 | 35 | 2020 |
The Dynamic Process of Drug–GPCR Binding at Either Orthosteric or Allosteric Sites Evaluated by Metadynamics S Schneider, D Provasi, M Filizola G Protein-Coupled Receptors in Drug Discovery: Methods and Protocols, 277-294, 2015 | 31 | 2015 |
ATTRACT and PTOOLS: Open Source Programs for Protein–Protein Docking S Schneider, A Saladin, S Fiorucci, C Prevost, M Zacharias Computational Drug Discovery and Design, 221-232, 2012 | 24 | 2012 |
The Discovery of Two Novel Classes of 5, 5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer RV Quiroz, MH Reutershan, SE Schneider, D Sloman, BM Lacey, ... Journal of Medicinal Chemistry, 2021 | 20 | 2021 |
Scoring optimisation of unbound protein–protein docking including protein binding site predictions S Schneider, M Zacharias Journal of Molecular Recognition 25 (1), 15-23, 2012 | 14 | 2012 |
Combining geometric pocket detection and desolvation properties to detect putative ligand binding sites on proteins S Schneider, M Zacharias Journal of structural biology 180 (3), 546-550, 2012 | 13 | 2012 |
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-b]furan Nucleoside Analogues DA Candito, Y Ye, RV Quiroz, MH Reutershan, D Witter, SB Gadamsetty, ... The Journal of Organic Chemistry, 2021 | 6 | 2021 |
Predicted mode of Binding of Non-Nitrogenous μ-Opioid Receptor Ligands by Metadynamics S Schneider, D Provasi, R Saylor, T Prisinzano, M Filizola Biophysical Journal 110 (3), 90a, 2016 | 2 | 2016 |
Prmt5 inhibitors J Lim, M Machacek, MH Reutershan, S Schneider US Patent App. 17/266,507, 2021 | 1 | 2021 |
Binding Pathways of a G-Protein Biased μ-opioid Receptor agonist under Clinical Evaluation S Schneider, D Provasi, M Filizola Biophysical Journal 3 (110), 591a, 2016 | 1 | 2016 |
CELLmicrocosmos 2.2: advancements and applications in modeling of three-dimensional PDB membranes B Sommer, T Dingersen, S Schneider, S Rubert, C Gamroth Journal of Cheminformatics 2 (Suppl 1), O21, 2010 | 1 | 2010 |
CELLmicrocosmos 2.2: advancements and applications in modeling of three-dimensional PDB membranes (Conference Abstract) B Sommer, T Dingersen, S Schneider, S Rubert, C Gamroth | 1* | 2010 |
CELLmicrocosmos 2.1: a software approach for the modelling of three-dimensional PDB membranes B Sommer, T Dingersen, S Schneider Chemistry Central Journal 3 (1), P72, 2009 | 1 | 2009 |
CELLmicrocosmos 2.1: a software approach for the modelling of three-dimensional PDB membranes (Conference Abstract) B Sommer, T Dingersen, S Schneider | 1* | 2009 |